Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

More than 75% of breast cancers that develop in BRCA1 mutation carriers are triple-negative breast cancers (TNBC). The aim of this study was to compare the recurrence-free survival (RFS) and overall survival (OS) in high-risk patients with TNBC with and without deleterious BRCA1/2 mutations. A total...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Breast Cancer Res Treat
Hoofdauteurs: Bayraktar, Soley, Gutierrez-Barrera, Angelica M., Liu, Diane, Tasbas, Tunc, Akar, Ugur, Litton, Jennifer K., Lin, E., Albarracin, Constance T., Meric-Bernstam, Funda, Gonzalez-Angulo, Ana M., Hortobagyi, Gabriel N., Arun, Banu K.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2011
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4334122/
https://ncbi.nlm.nih.gov/pubmed/21830012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-011-1711-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items